Legal Representation
Attorney
Catherine C. Miller
USPTO Deadlines
Next Deadline
171 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200623)
Due Date
June 23, 2026
Grace Period Ends
December 23, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 23, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Apr 15, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 2, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 13, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Oct 13, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 23, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 23, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 7, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 7, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 18, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 28, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 21, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 18, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 18, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 18, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 18, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 18, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 18, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 13, 2020 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Oct 24, 2019 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Sep 27, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 6, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 5, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Aug 16, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Aug 15, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 14, 2019 | RFWR | P | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | Loading... |
| Jul 29, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 28, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 24, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 20, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 20, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 18, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemicals used in industry and science, in particular for use in biotechnology, pharmaceutics, medicine and veterinary medicine
Class 005
Pharmaceutical and veterinary preparations, namely, preparations for the prevention and treatment of proliferative diseases, cancers, infectious diseases, autoimmune diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines, in particular DNA-based and RNA-based vaccines, adjuvant preparations for use with vaccines, nucleic acids sequences, proteins, and chemical reagents for medical and veterinary purposes, protein conjugates, peptides, in particular antibodies and tumour markers; cell-based immunotherapeutic treatment, namely, by way of genetically modified cells, medicated serums for the treatment of proliferating diseases, cancers, infectious diseases, and autoimmune diseases, attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes
Class 042
Scientific research and development in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, in particular scientific research and development in the field of medical and veterinary diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, screening for pharmaceutically active compounds; scientific research and development of diagnostic methods and test processes; research and development of supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific study and research in the field of medicine; scientific research and development for medical and veterinary purposes; scientific study and research in the field of pharmaceuticals; medical and pharmaceutical consultation, namely, testing, analysis and evaluation of goods and services of others to determine conformity with certification standards
Class 044
Medical services; medical care and consultancy; pharmaceutical and medical consultancy; information and advisory services in the healthcare field; preparation of reports relating to medical and pharmaceutical matters
Additional Information
Design Mark
The mark consists of a circle enclosing five wavy lines fanning out from a bottom portion of the circle perimeter terminating at upper portion of the circle perimeter where each of the five wavy lines are made up of small spaced-apart squares.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
042
044